ArticleJournal of robotic surgery2025
Introducing Senhance robotic totally extraperitoneal (TEP) hernioplasty: initial experiences, learning curve, and mid-term outcomes from a single center.
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laparoscopic totally extraperitoneal (TEP) inguinal hernioplasty offers less pain and faster recovery than open repair, but it is technically demanding. The Senhance surgical system integrates eye-tracking, haptic feedback, and reusable instruments; however, robust clinical data in TEP remain limited. Between January 2019 and July 2023, we prospectively enrolled 109 adults who underwent Senhance-assisted TEP (S-TEP) at a single center; 57 retrospective laparoscopic TEP (L-TEP) served as an operative-time benchmark. Patients with prior pelvic-malignancy surgery, ascites, peritoneal dialysis, emergency surgeries, or general anesthesia intolerance were excluded. Patient demographics, hernia type, operative time, 30-day complications, pain scores, length of stay, recurrence, and chronic pain were recorded systematically. We used cumulative-sum (CUSUM) analysis to assess the learning curve, and compare the operative-time with L-TEP after overlap weighing balance. All S-TEP procedures were completed robotically without conversions or intra-operative complications. CUSUM revealed a three-phase learning curve, reaching proficiency after ≈50 cases as mean operative time fell from 145 ± 32 min to 93 ± 18 min (p < 0.001). Thirty-day morbidity was 6.4%, mainly early seroma or hematoma. At a median 50-month follow-up, recurrence and chronic pain rates were 0.9 and 1.8%, respectively. Weighted analysis showed that operative time in the mature S-TEP phase matched L-TEP. S-TEP is feasible and safe for inguinal hernioplasty, achieving favorable mid-term outcomes comparable to laparoscopic standards after a learning curve of roughly 50 cases. Further validation through larger, multicenter studies are warranted.
Indexed as
Identifiers
40555886What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.